With 2,475 employees, Helmholtz Munich is investigating how diabetes, allergies and chronic lung diseases are triggered by environmental influences. The scientists use the knowledge gained in this way to develop innovative therapeutic approaches and new medicines.
The center also provides scientifically validated information to patients, relatives and interested parties via several online platforms. The aim of Helmholtz is to gain a better understanding of environmental diseases in order to break new ground in diagnostics, therapy and prevention.